Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward V Loftus

Showing results (61-70 of 471) with videos related to

Pageof 48
Sort By:
Gastroenterology & Hepatology|May 26, 2021
Impact of Obesity on the Management of Inflammatory Bowel DiseaseAmanda M Johnson, Edward V Loftus
Current Gastroenterology Reports|November 30, 2005
Evolving diagnostic modalities in inflammatory bowel diseaseJonathan A Leighton, Edward V Loftus
Journal of Crohn'S & Colitis|April 29, 2017
Response to 'Preoperative Vedolizumab and Postoperative Outcomes in Inflammatory Bowel Disease: Does Smoke Always Mean Fire?'Amy L Lightner, Edward V Loftus
Gastroenterology|October 31, 2002
Cancer risk in celiac diseaseConor G Loftus, Edward V Loftus
Gastroenterology Clinics of North America|July 19, 2002
Epidemiology of inflammatory bowel diseaseEdward V Loftus, William J Sandborn
Current Gastroenterology Reports|November 12, 2009
Diagnostic advances in inflammatory bowel disease (imaging and laboratory)Maria E Moscandrew, Edward V Loftus
Current Opinion in Gastroenterology|May 7, 2016
Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?Sushil K Garg, Edward V Loftus
Current Gastroenterology Reports|April 2, 2008
Current and future diagnostic approaches: from serologies to imagingDavid H Bruining, Edward V Loftus
JAMA|January 22, 2025
Risankizumab for Ulcerative Colitis-ReplyEdouard Louis, Jasmina Kalabic, Edward V Loftus
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 7, 2023
Therapeutic Drug Monitoring for Subcutaneous Infliximab? Too Early to ConcludeEdward V Loftus, Stephàne Paul, Xavier Roblin
Pageof 48

Showing results (61-70 of 471) with videos related to

Sort By:
Pageof 48
Gastroenterology & Hepatology|May 26, 2021
Impact of Obesity on the Management of Inflammatory Bowel DiseaseAmanda M Johnson, Edward V Loftus
Current Gastroenterology Reports|November 30, 2005
Evolving diagnostic modalities in inflammatory bowel diseaseJonathan A Leighton, Edward V Loftus
Journal of Crohn'S & Colitis|April 29, 2017
Response to 'Preoperative Vedolizumab and Postoperative Outcomes in Inflammatory Bowel Disease: Does Smoke Always Mean Fire?'Amy L Lightner, Edward V Loftus
Gastroenterology|October 31, 2002
Cancer risk in celiac diseaseConor G Loftus, Edward V Loftus
Gastroenterology Clinics of North America|July 19, 2002
Epidemiology of inflammatory bowel diseaseEdward V Loftus, William J Sandborn
Current Gastroenterology Reports|November 12, 2009
Diagnostic advances in inflammatory bowel disease (imaging and laboratory)Maria E Moscandrew, Edward V Loftus
Current Opinion in Gastroenterology|May 7, 2016
Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?Sushil K Garg, Edward V Loftus
Current Gastroenterology Reports|April 2, 2008
Current and future diagnostic approaches: from serologies to imagingDavid H Bruining, Edward V Loftus
JAMA|January 22, 2025
Risankizumab for Ulcerative Colitis-ReplyEdouard Louis, Jasmina Kalabic, Edward V Loftus
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 7, 2023
Therapeutic Drug Monitoring for Subcutaneous Infliximab? Too Early to ConcludeEdward V Loftus, Stephàne Paul, Xavier Roblin
Pageof 48